Keene Brandon A.
- SEC CIK
- 0001859733
No open-market purchases or sales filed in the past year.
Current role at each company
- SRTA Strata Critical Medical, Inc.Chief Innovation Officeras of Nov 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Keene Brandon A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 (view filing) | Nov 18 | 3 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −29.1K | $4.79 | −$139.4K | −8.4%318.6K after | 2 lots |
| Oct 11, 2022 (view filing) | Oct 6 | 5 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −1.28K | $3.97 | −$5.09K | −0.4%347.7K after | |
| Sep 14, 2022 (view filing) | Sep 12-14 | 2 days | Keene Brandon A.Chief Innovation Officer | SSaleClass A common stock, $0.0001 par value per share | −50.0K | $4.79 | −$239.3K | −12.5%349.0K after | 3 lots |